Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals

Post time 2024-4-2 13:19:25

journal：Metabolic Syndrome and Related Disorders

Authors：Ranakishor Pelluri; Srikanth Kongara; Vanitha Rani Nagasubramanian; Shriraam Mahadevan; Jithendra Chimakurthy

Published date：2024-3-1

DOI：10.1089/met.2023.0218

PDF link：https://www.liebertpub.com/doi/full-xml/10.1089/met.2023.0218

Article link：http://dx.doi.org/10.1089/met.2023.0218

Article Source：Mary Ann Liebert Inc。

Remark：

Post time 2024-4-2 13:19:26

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Liebert] Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Liebert] Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Liebert] Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals